Retrograde transvenous obliteration of gastric varices associated with large collateral veins or a large gastrorenal shunt

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 1, 2005, Pages 113-118

  Sugimori, Kazuya ^a   Morimoto, Manabu ^a   Shirato, Kazuhito ^a   Kokawa, Atsushi ^a   Tomita, Naohiko ^a   Numata, Kazushi ^a   Saito, Toshifumi ^a   Tanaka, Katsuaki ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IOPAMIDOL; MONOETHANOLAMINE OLEATE; ODAMIN; SCLEROSING AGENT;

ADULT; AGED; ARTICLE; BALLOON; BALLOON CATHETER; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; RECURRENCE RISK; STOMACH VARICES; TECHNIQUE; TREATMENT OUTCOME;

EID: 11844297797     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000143765.38128.23     Document Type: Article

References (22)

1. Binmoeller KF, Borsatto R. Variceal bleeding and portal hypertension. Endoscopy 2000; 32:189-199.
2. Idezuki Y. Present status of sclerotherapy and surgical treatment for esophageal varices in Japan. Japanese Research Society for Portal Hypertension and Japanese Research Society for Sclerotherepy of Esophageal Varices. World J Surg 1992; 16:1193-1201.
3. Sarin SK, Sachdev G, Nanda R, Misra SP, Broor SL. Endoscopic sclerotherapy in the treatment of gastric varices. Br J Surg 1988; 75:747-750.
4. Sandy H. The role of sclerotherapy in the treatment of esophageal varices: personal experience and a review of randomized trials. Am J Gastroenterol 1987; 82:813-822.
5. Korula L, Chin K, Ko Y, Yamada S. Demonstration of two distinct subsets of gastric varices: observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci 1991; 36:303-309.
6. Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portocaval shunt: an experimental study. Radiology 1969; 92:1112-1114.
7. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889-898.
8. Kerlan RK Jr, LaBerge JM, Baker EL, et al. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic porto-systemic shunts. J Vasc Interv Radiol 1995; 6:917-921.
9. Brown RS Jr., Lake JR. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indication and contraindications. Adv Intern Med 1997; 42:485-504.
10. Somberg KA. TIPS: safe, effective, better? [editorial]. Am J Gastroenterol 1997; 92:1412-1416.
11. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11:51-58.
12. Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol 1996; 167:1317-1320.
13. Akahane T, Iwasaki T, Kobayashi N, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997; 92:1026-1030.
14. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211:349-356.
15. Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol 1999; 94:643-649.
16. Kawanaka H, Ohta M, Hashizume M, et al. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1995; 90:508-510.
17. Numata K, Tanaka K, Kiba T, et al. Use of balloon-occluded retrograde transvenous obliteration with ethanolamine oleate for the treatment of hepatic encephalopathy in a cirrhotic patient with a large spontaneous splenorenal shunt. J Gastroenterol 1998; 33:424-427.
18. Sonomura T, Sato M, Kishi K, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol 1998; 21:27-30.
19. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12:327-336.
20. Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J Surg 1995; 19:420-422.
21. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 1990; 36:276-280.
22. Miyoshi H, Oshiba S, Matsumoto A, Takada K, Umegaki E, Hirata I. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate. Am J Gastroenterol 1991; 86:1638-1641.